Cargando…
Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt
BACKGROUND: Fascioliasis is a neglected zoonosis with major public health implications in humans. Although triclabendazole (TCBZ) is the drug of choice, there are records of TCBZ failure worldwide. TCBZ-resistant fascioliasis is treated with alternative approved drugs including nitazoxanide (NTZ), w...
Autores principales: | Ramadan, Haidi Karam-Allah, Hassan, Waleed Attia, Elossily, Nahed Ahmed, Ahmad, Alzahraa Abdelraouf, Mohamed, Adnan Ahmed, Abd- Elkader, Alaa Soliman, Abdelsalam, Eman M. Nagiub, Khojah, Hani M. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779272/ https://www.ncbi.nlm.nih.gov/pubmed/31553716 http://dx.doi.org/10.1371/journal.pntd.0007779 |
Ejemplares similares
-
Correction: Evaluation of nitazoxanide treatment following triclabendazole failure in an outbreak of human fascioliasis in Upper Egypt
por: Ramadan, Haidi Karam-Allah, et al.
Publicado: (2020) -
New perspectives for fascioliasis in Upper Egypt’s new endemic region: Sociodemographic characteristics and phylogenetic analysis of Fasciola in humans, animals, and lymnaeid vectors
por: Ahmad, Alzahraa Abdelraouf, et al.
Publicado: (2022) -
Clinical characteristics of human fascioliasis in Egypt
por: Ibrahim, Nagat, et al.
Publicado: (2023) -
Triclabendazole in the treatment of human fascioliasis: a review
por: Gandhi, Preetam, et al.
Publicado: (2019) -
Dengue fever as a reemerging disease in upper Egypt: Diagnosis, vector surveillance and genetic diversity using RT-LAMP assay
por: Gaber, Mona, et al.
Publicado: (2022)